Expertise in
5
conditions

Qun M. Hu

Jiangsu Key Laboratory Of Crop Genetics And Physiology/Jiangsu Key Laboratory Of Crop Cultivation And Physiology, 
Yangzhou, CN 
Expertise in
5
conditions
Jiangsu Key Laboratory Of Crop Genetics And Physiology/Jiangsu Key Laboratory Of Crop Cultivation And Physiology, 
Yangzhou, CN 

Overview

Qun Hu practices practicing medicine in Yangzhou, China.

Hu is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Hemophilia A, Blood Clots, Hereditary Spherocytosis, Acute Lymphoblastic Leukemia (ALL), and Splenectomy.

They are actively involved in clinical research, co-authoring 96 peer reviewed articles and participating in 1 clinical trial.

Locations

Jiangsu Key Laboratory Of Crop Genetics And Physiology/Jiangsu Key Laboratory Of Crop Cultivation And Physiology, Yangzhou, 225009, China
Other Locations
Wuhan, China
Yangzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
Enrollment Status: Terminated
Publish Date: October 02, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 1/Phase 2

96 Total Publications

Foliar Silicon Application at Multiple Growth Stages Can Improve Lodging Resistance, Yield, and Grain Quality in Rice.
Foliar Silicon Application at Multiple Growth Stages Can Improve Lodging Resistance, Yield, and Grain Quality in Rice.
Journal: Plants (Basel, Switzerland)
Published: June 09, 2026

Frequently Asked Questions about Qun M. Hu

Is Qun M. Hu a top-rated expert for Hemophilia A?

MediFind is an objective health platform that identifies experts based on real-world data. Qun M. Hu is classified as an Distinguished expert for Hemophilia A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Qun M. Hu participate in research or clinical trials?

Yes. Qun M. Hu has published 96 articles and abstracts on conditions like Hemophilia A. You can view a list of Qun M. Hu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hu's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile